REGENEUS LTD (ASX:RGS)
Industry: Classification Pending
Activity: Regenerative medicine.
25 Bridge Street PYMBLE NSW 2073
Ph: (02) 9499 8010    Fax: (02) 9499 8020
Duncan Thomson
Wed, 13 Nov 2013 1:30pm
Duncan Thomson, Head of Animal Health
Icon_lastIcon_nextIcon_previousIcon_first
Interim Results
Thu, 19 Feb 2015
Annual General Meeting
Tue, 28 Oct 2014
Full Year Results
Mon, 25 Aug 2014
Interim Results
Thu, 27 Feb 2014
Annual General Meeting
Wed, 27 Nov 2013
Regeneus receives R&D tax incentive refund of $2.7m Mon, 12 Sep 2016
Appendix 4E and Annual Report 2016 Wed, 24 Aug 2016
Appendix 4G and Corporate Governance Statement Wed, 24 Aug 2016
FY16 Results Announcement Wed, 24 Aug 2016
FY16 Results Presentation Wed, 24 Aug 2016
Date of AGM Tue, 9 Aug 2016
Response to ASX Price Query Fri, 5 Aug 2016
European patent to grant on stem cell secretions for acne Mon, 1 Aug 2016
Appendix 4C - Quarterly Fri, 29 Jul 2016
Q2 2016 Update Fri, 1 Jul 2016

Please note: This company appears on this website as a result of its listing on the Australian Securities Exchange. BRR Media does not claim any association with any company listed on this site.